Cancer Control & Population Sciences
Cancer Therapeutics & Host Response
Cancer Control & Population Sciences
Butala AA, Huang CC, Bryant CM, Henderson RH, Hoppe BS, Mendenhall NP, Vapiwala N, Mailhot Vega RB. Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity. Value Health. 2022 Feb;25(2):171-177. doi: 10.1016/j.jval.2021.08.010. Epub 2021 Oct 22. PubMed PMID: 35094789.
Campbell-Salome G, Fisher CL, Wright KB, Lincoln G, Applebaum AJ, Sae-Hau M, Weiss ES, Bylund CL. Impact of the family communication environment on burden and clinical communication in blood cancer caregiving. Psychooncology. 2022 Feb 26. doi: 10.1002/pon.5910. [Epub ahead of print] PubMed PMID: 35218278.
Indelicato DJ, Mailhot Vega RB, Viviers E, Morris CG, Bradfield SM, Gibbs CP, Bradley JA. Modern Therapy for Chest Wall Ewing Sarcoma: An Update of the XXX Experience. Int J Radiat Oncol Biol Phys. 2022 Feb 14. pii: S0360-3016(22)00157-2. doi: 10.1016/j.ijrobp.2022.02.011. [Epub ahead of print] PubMed PMID: 35176415.
Ali A, Xie Z, Stanko L, De Leo E, Hong YR, Bian J, Daily KC. Endocrine adherence in male versus female breast cancer: a seer-medicare review. Breast Cancer Res Treat. 2022 Feb 10. doi: 10.1007/s10549-022-06536-0. [Epub ahead of print] Review. PubMed PMID: 35142938.
Kim J, Lee JH. A novel graphical evaluation of agreement. BMC Med Res Methodol. 2022 Feb 20;22(1):51. doi: 10.1186/s12874-022-01532-w. PubMed PMID: 35184729; PubMed Central PMCID: PMC8858529.
Abi Nehme AM, Lou X, Yan X, Lee JH, Salloum RG. Transition to smoking cessation among dual cigarette and e-cigarette users in the population assessment of tobacco and health study, Waves 3 and 4 (2015-2017). Addict Behav. 2022 Feb 17;129:107284. doi: 10.1016/j.addbeh.2022.107284. [Epub ahead of print] PubMed PMID: 35217415.
De Leo AN, Dagan R, Amdur RJ, Yeung AR, Li J, Brooks ED, Gilbo P, Gomez D, Chang JY, Ning M. How Three Academic Centers Prescribe SBRT for Primary Lung Cancer. Pract Radiat Oncol. 2022 Feb 24. pii: S1879-8500(22)00067-4. doi: 10.1016/j.prro.2022.02.006. [Epub ahead of print] PubMed PMID: 35219881.
Serie DJ, Myers AA, Haehn DA, Parker AS, Bajalia EM, Gonzalez GA, Li Q, Wong MY, Moser KC, Zhou B, Thiel DD. Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma. Urol Oncol. 2022 Feb 8. pii: S1078-1439(21)00554-8. doi: 10.1016/j.urolonc.2021.12.005. [Epub ahead of print] PubMed PMID: 35148948.
Ponce SB, M Barry M, S Dizon D, S Katz M, Murphy M, Teplinsky E, Tinianov S, J Attai D, Markham MJ. Netiquette for social media engagement for oncology professionals. Future Oncol. 2022 Feb 3. doi: 10.2217/fon-2021-1366. [Epub ahead of print] Review. PubMed PMID: 35109663.
Pather K, Mobley EM, Guerrier C, Esma R, Kendall H, Awad ZT. Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy. World J Surg Oncol. 2022 Feb 25;20(1):50. doi: 10.1186/s12957-022-02518-0. Review. PubMed PMID: 35209914.
Penha D, Pinto E, Monaghan C, Hochhegger B, Marchiori E, Taborda-Barata L, Irion K, Ravara S, Kauczor HU. Incidental findings on lung cancer screening: pictorial essay and systematic checklist. J Bras Pneumol. 2022 Feb 2;48(1):e20210371. doi: 10.36416/1806-3756/e20210371. eCollection 2022. English, Portuguese. PubMed PMID: 35137873.
Stapleton SJ, Dyal BW, Boyd AD, Suarez ML, Ezenwa MO, Yao Y, Wilkie DJ. Adherence to Analgesics Among Outpatients Seriously Ill With Cancer. Cancer Nurs. 2022 Feb 16. doi: 10.1097/NCC.0000000000001064. [Epub ahead of print] PubMed PMID: 35175950.
Kwan ML, Miglioretti DL, Bowles EJA, Weinmann S, Greenlee RT, Stout NK, Rahm AK, Alber SA, Pequeno P, Moy LM, Stewart C, Fong C, Jenkins CL, Kohnhorst D, Luce C, Mor JM, Munneke JR, Prado Y, Buth G, Cheng SY, Deosaransingh KA, Francisco M, Lakoma M, Martinez YT, Theis MK, Marlow EC, Kushi LH, Duncan JR, Bolch WE, Pole JD, Smith-Bindman R. Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile. Cancer Causes Control. 2022 Feb 2. doi: 10.1007/s10552-022-01556-z. [Epub ahead of print] PubMed PMID: 35107724.
Yaghjyan L, Darville LNF, Cline J, Martinez YC, Rich S, Austin-Datta RJ, Koomen JM, Tworoger SS, Egan KM. Associations of established breast cancer risk factors with urinary estrogens in postmenopausal women. Cancer Causes Control. 2022 Feb;33(2):279-291. doi: 10.1007/s10552-021-01528-9. Epub 2022 Jan 6. PubMed PMID: 34988766.
Winders S, Lyon DE, Stechmiller JK, Kelly DL. Biomarkers of sleep disturbance in adults with chronic illness: A scoping review. Chronic Illn. 2022 Feb 18:17423953211073697. doi: 10.1177/17423953211073697. [Epub ahead of print] PubMed PMID: 35179070.
Alpert JM, Taylor G, Hampton CN, Paige S, Markham MJ, Bylund CL. Clinicians’ Perceptions of the Benefits and Challenges of Teleoncology as Experienced Through the COVID-19 Pandemic: Qualitative Study. JMIR Cancer. 2022 Feb 24;8(1):e34895. doi: 10.2196/34895. PubMed PMID: 35142622.
Cancer Therapeutics & Host Response
Chen D, Le SB, Hutchinson TE, Calinescu AA, Sebastian M, Jin D, Liu T, Rahman M. Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J Clin Invest. 2022 Feb 24. pii: e149258. doi: 10.1172/JCI149258. [Epub ahead of print] PubMed PMID: 35199647.
Ogando-Rivas E, Castillo P, Jones N, Trivedi V, Drake J, Dechkovskaia A, Candelario KM, Yang C, Mitchell DA. Effects of immune checkpoint blockade on antigen-specific CD8+ T cells for use in adoptive cellular therapy. Microbiol Immunol. 2022 Feb 12. doi: 10.1111/1348-0421.12967. [Epub ahead of print] PubMed PMID: 35150167.
Luo H, Zhu G, Eshelman MA, Fung TK, Lai Q, Wang F, Zeisig BB, Lesperance J, Ma X, Chen S, Cesari N, Cogle C, Chen B, Xu B, Yang FC, So CWE, Qiu Y, Xu M, Huang S. HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia. Mol Cell. 2022 Feb 17;82(4):833-851.e11. doi: 10.1016/j.molcel.2022.01.014. PubMed PMID: 35180428.
Greer JA, Moy B, El-Jawahri A, Jackson VA, Kamdar M, Jacobsen J, Lindvall C, Shin JA, Rinaldi S, Carlson HA, Sousa A, Gallagher ER, Li Z, Moran S, Ruddy M, Anand MV, Carp JE, Temel JS. Randomized Trial of a Palliative Care Intervention to Improve End-of-Life Care Discussions in Patients With Metastatic Breast Cancer. J Natl Compr Canc Netw. 2022 Feb;20(2):136-143. doi: 10.6004/jnccn.2021.7040. PubMed PMID: 35130492; PubMed Central PMCID: PMC8830600.
Guest EM, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang CY, Devidas M, Gore L, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Borowitz M, Loh ML, Hunger SP, Brown PA. Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial. Haematologica. 2022 Feb 17. doi: 10.3324/haematol.2021.280146. [Epub ahead of print] PubMed PMID: 35172563.
Butala AA, Huang CC, Bryant CM, Henderson RH, Hoppe BS, Mendenhall NP, Vapiwala N, Mailhot Vega RB. Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity. Value Health. 2022 Feb;25(2):171-177. doi: 10.1016/j.jval.2021.08.010. Epub 2021 Oct 22. PubMed PMID: 35094789.
Comer JC, King RB, Harris AB, Hitchcock KE, Mendenhall WM, Bates JE, Dziegielewski PT. Retromolar trigone squamous cell carcinoma: A population-based analysis of survival. Oral Oncol. 2022 Feb 22;127:105767. doi: 10.1016/j.oraloncology.2022.105767. [Epub ahead of print] PubMed PMID: 35217400.
Huigens RW 3rd, Brummel BR, Tenneti S, Garrison AT, Xiao T. Pyrazine and Phenazine Heterocycles: Platforms for Total Synthesis and Drug Discovery. Molecules. 2022 Feb 7;27(3). pii: 1112. doi: 10.3390/molecules27031112. Review. PubMed PMID: 35164376; PubMed Central PMCID: PMC8839373.
Brumley DA, Gunasekera SP, Sauvage T, Dos Santos LAH, Chen QY, Paul VJ, Luesch H. Discovery, Synthesis, and Biological Evaluation of Anaenamides C and D from a New Marine Cyanobacterium, Hormoscilla sp. J Nat Prod. 2022 Feb 15. doi: 10.1021/acs.jnatprod.1c01073. [Epub ahead of print] PubMed PMID: 35167289.
Flores C, Dunn G, Fecci P, Lim M, Mitchell D, Reardon DA. Is There a Role for Immunotherapy in Central Nervous System Cancers? Hematol Oncol Clin North Am. 2022 Feb;36(1):237-252. doi: 10.1016/j.hoc.2021.09.002. Review. PubMed PMID: 34801163.
De Leo AN, Dagan R, Amdur RJ, Yeung AR, Li J, Brooks ED, Gilbo P, Gomez D, Chang JY, Ning M. How Three Academic Centers Prescribe SBRT for Primary Lung Cancer. Pract Radiat Oncol. 2022 Feb 24. pii: S1879-8500(22)00067-4. doi: 10.1016/j.prro.2022.02.006. [Epub ahead of print] PubMed PMID: 35219881.
Huang F, Bailey LS, Gao T, Jiang W, Yu L, Bennett DA, Zhao J, Basso KB, Guo Z. Analysis and Comparison of Mouse and Human Brain Gangliosides via Two-Stage Matching of MS/MS Spectra. ACS Omega. 2022 Feb 10;7(7):6403-6411. doi: 10.1021/acsomega.1c07070. eCollection 2022 Feb 22. PubMed PMID: 35224401; PubMed Central PMCID: PMC8867566.
Dursun F, Mackay A, Guzman JCA, Wenker E, Klaassen Z, O’Malley P, Bhindi B, Perez CO, Xu J, Roh T, Sonpavde G, Wallis CJD, Satkunasivam R. Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database. Urol Oncol. 2022 Feb;40(2):61.e21-61.e28. doi: 10.1016/j.urolonc.2021.07.015. Epub 2021 Aug 1. PubMed PMID: 34348861.
Grady C, Melnick K, Porche K, Dastmalchi F, Hoh D, Rahman M, Ghiaseddin A. Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas. Neurospine. 2022 Feb 2. doi: 10.14245/ns.2143210.605. [Epub ahead of print] PubMed PMID: 35130421.
Ponce SB, M Barry M, S Dizon D, S Katz M, Murphy M, Teplinsky E, Tinianov S, J Attai D, Markham MJ. Netiquette for social media engagement for oncology professionals. Future Oncol. 2022 Feb 3. doi: 10.2217/fon-2021-1366. [Epub ahead of print] Review. PubMed PMID: 35109663.
Vo KT, DuBois SG, Neuhaus J, Braunstein SE, Weil BR, Naranjo A, Irtan S, Balaguer J, Matthay KK. Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2022 Feb 21:e29616. doi: 10.1002/pbc.29616. [Epub ahead of print] PubMed PMID: 35188340.
Helman SL, Zhou J, Fuqua BK, Lu Y, Collins JF, Chen H, Vulpe CD, Anderson GJ, Frazer DM. The biology of mammalian multi-copper ferroxidases. Biometals. 2022 Feb 15. doi: 10.1007/s10534-022-00370-z. [Epub ahead of print] Review. PubMed PMID: 35167013.
Shoraka M, Wang S, Carbajal-Mamani SL, Han H, Amaro B, Cardenas-Goicoechea J. Oncologic outcomes in older women with endometrial carcinoma (â¥70 years). J Obstet Gynaecol. 2022 Feb 15:1-7. doi: 10.1080/01443615.2022.2033962. [Epub ahead of print] PubMed PMID: 35166187.
Alpert JM, Taylor G, Hampton CN, Paige S, Markham MJ, Bylund CL. Clinicians’ Perceptions of the Benefits and Challenges of Teleoncology as Experienced Through the COVID-19 Pandemic: Qualitative Study. JMIR Cancer. 2022 Feb 24;8(1):e34895. doi: 10.2196/34895. PubMed PMID: 35142622.
Sam SS, Stewart B, Nasri E, Leon ME, Martinez Duarte E. Leiomyosarcoma of the Nasal Cavity and Paranasal Sinuses: A Case Report and Comprehensive Review of the Literature. Head Neck Pathol. 2022 Feb 14. doi: 10.1007/s12105-022-01427-8. [Epub ahead of print] PubMed PMID: 35157212.
Mechanisms of Oncogenesis
Sekula M, Gaskins J, Datta S,. Single-Cell Differential Network Analysis with Sparse Bayesian Factor Models. Front Genet. 2022 Feb 4;12:810816. doi: 10.3389/fgene.2021.810816. eCollection 2021. PubMed PMID: 35186014; PubMed Central PMCID: PMC8855158.
Purayil HT, Daaka Y. βArrestin1 regulates glucocorticoid receptor mitogenic signaling in castration-resistant prostate cancer. Prostate. 2022 Feb 28. doi: 10.1002/pros.24324. [Epub ahead of print] PubMed PMID: 35226379.
Lee B, Mohamad I, Pokhrel R, Murad R, Yuan M, Stapleton S, Bettegowda C, Jallo G, Eberhart CG, Garrett T, Perera RJ. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs. Acta Neuropathol Commun. 2022 Feb 24;10(1):25. doi: 10.1186/s40478-022-01326-7. PubMed PMID: 35209946; PubMed Central PMCID: PMC8867780.